Globus Medical Q4 Revenue $826M Up 25.7%, EPS $1.28 Tops Estimates
Globus Medical reported Q4 revenue of $826.4 million, up 25.7% year-over-year, beating the $787.9 million consensus by 4.9%. EPS reached $1.28, topping the $1.06 estimate by 20.8%, with U.S. sales up 27.5% to $665.3 million and international revenues rising 19% to $161.1 million.
1. Q4 Financial Highlights
Globus Medical posted Q4 revenue of $826.42 million, up 25.7% from Q4 2024, surpassing the $787.85 million consensus by 4.9%. Earnings per share were $1.28, rising from $0.84 a year ago and exceeding the $1.06 estimate by 20.8%.
2. Geographic Revenue Breakdown
Domestic sales reached $665.32 million, a 27.5% increase and $43.4 million above analyst forecasts of $621.92 million, while international revenue climbed 19% to $161.1 million, outpacing estimates of $147.72 million.
3. Product Category Sales Growth
Net sales of musculoskeletal solutions rose 26.3% year-over-year to $770.8 million, beating the $735.95 million target, and enabling technologies advanced 18.5% to $55.62 million versus the $33.7 million forecast.